References
- Jilek BL, Zarr M, Sampah ME et al. A quantitative basis for antiretroviral therapy for HIV-1 infection. Nat. Med. 18(3), 446–451 (2012).
- Chun TW, Justement JS, Murray D et al. Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication. AIDS 24(18), 2803–2808 (2010).
- Joos B, Fischer M, Kuster H et al.; Swiss HIV Cohort Study. HIV rebounds from latently infected cells, rather than from continuing low-level replication. Proc. Natl Acad. Sci. USA 105(43), 16725–16730 (2008).
- Sedaghat AR, Siliciano RF, Wilke CO. Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART. BMC Infect. Dis. 8, 2 (2008).
- Palmer S, Maldarelli F, Wiegand A et al. Low-level viremia persists for at least 7years in patients on suppressive antiretroviral therapy. Proc. Natl Acad. Sci. USA 105(10), 3879–3884 (2008).
- Perelson AS, Essunger P, Cao Y et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387(6629), 188–191 (1997).
- Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics invivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271(5255), 1582–1586 (1996).
- Chun TW, Carruth L, Finzi D et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387(6629), 183–188 (1997).
- Chomont N, El-Far M, Ancuta P et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. Med. 15(8), 893–900 (2009).
- Eckstein DA, Penn ML, Korin YD et al. HIV-1 actively replicates in naive CD4(+)T cells residing within human lymphoid tissues. Immunity 15(4), 671–682 (2001).
- Buzón MJ, Massanella M, Llibre JM et al. HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Nat. Med. 16(4), 460–465 (2010).
- Margolis DM. Histone deacetylase inhibitors and HIV latency. Curr. Opin. HIV AIDS 6(1), 25–29 (2011).
- Archin NM, Espeseth A, Parker D, Cheema M, Hazuda D, Margolis DM. Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. AIDS Res. Hum. Retroviruses 25(2), 207–212 (2009).
- Miller-Jensen K, Dey SS, Pham N, Foley JE, Arkin AP, Schaffer DV. Chromatin accessibility at the HIV LTR promoter sets a threshold for NF-kB mediated viral gene expression. Integr. Biol. (Cam.) 4(6), 661–671 (2012).
- Denton PW, Krisko JF, Powell DA et al. Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice. PLoS ONE 5(1), e8829 (2010).
- Denton PW, Olesen R, Choudhary SK et al. Generation of HIV latency in humanized BLT mice. J. Virol. 86(1), 630–634 (2012).
- Ling B, Mohan M, Lackner AA et al. Thelarge intestine as a major reservoir forsimian immunodeficiency virus in macaques with long-term, nonprogressing infection. J. Infect. Dis. 202(12), 1846–1854 (2010).
- Kearney M, Spindler J, Shao W et al. Genetic diversity of simian immunodeficiency virus encoding HIV-1 reverse transcriptase persists in macaques despite antiretroviral therapy. J. Virol. 85(2), 1067–1076 (2011).
- Shan L, Deng K, Shroff NS et al. Stimulation of HIV-1-specific cytolytic Tlymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity 36(3), 491–501 (2012).
- Wu X, Zhou T, Zhu J et al.; NISC Comparative Sequencing Program. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 333(6049), 1593–1602 (2011).